Henry Gosebruch, Lakefront Biotherapeutics CEO May 13, 2026 09:30 AM EDT PeopleR&DPharma Behind Galapagos’ transformation into Lakefront Biotherapeutics Kyle LaHucik Biotech Correspondent CHICAGO — From a 22nd-floor office overlooking the Chicago Riverwalk, in the heart of the Midwest hub’s white-collar downtown district, Lakefront Biotherapeutics’ executives hope to stage … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
endpoints· 2mo ago
saveBehind Galapagos’ transformation into Lakefront Biotherapeutics
May 13, 2026read original ↗
CHICAGO — From a 22nd-floor office overlooking the Chicago Riverwalk, in the heart of the Midwest hub’s white-collar downtown district, Lakefront Biotherapeutics’ executives hope to stage the company’s turnaround.
83 words · extracted 2mo agoread original ↗
🔗 mentioned in this article
no entities indexed yet
comments(0)
5-min edit window · permanent after that